LIN.NASDAQLinde PLC

Form 4: Linde Director Stephen Angel's Share Transactions

Sentiment:

Insider Transaction Report


Linde PLC Director Stephen F. Angel reported exercising stock options, selling shares, and changes in his beneficial ownership of company stock.

Summary

  • Director Stephen F. Angel of Linde PLC reported transactions on August 7, 2025, including the exercise of stock options and subsequent share dispositions.
  • Angel exercised 125,000 stock options at an exercise price of $118.71 per share.
  • Following the option exercise, 74,691 ordinary shares were disposed of at $474.94 per share to cover exercise price and tax withholdings.
  • An additional 50,309 ordinary shares were sold at a weighted average price of $473.38 per share, with individual sale prices ranging from $471.39 to $474.62.
  • After these transactions, Angel's direct beneficial ownership of ordinary shares stands at 480,542.502.
  • Indirect beneficial ownership includes 71,029 shares via the 2010 Descendants Trust, 20,517 shares via the 2012 Descendants Trust, 2,268 shares in trust for children, and 11,152.107 shares in a 401(k).
  • The director also holds various unvested Restricted Stock Units (RSUs) and unexercised Stock Options, representing significant potential future share acquisition.

Sentiment

Score: 6

Explanation: The filing details a pre-planned monetization of stock options by a director, which is a common and expected event for executives. While it involves a sale of shares, it's not an open-market sale indicating a lack of confidence, but rather a realization of value from long-term incentives. The director retains substantial equity holdings, including unvested awards, maintaining alignment with shareholder interests.

Positives

  • The exercise of 125,000 stock options at a price of $118.71, significantly below the market price, indicates the director's ability to realize substantial value from long-term incentives.
  • The director retains substantial beneficial ownership, including 480,542.502 direct ordinary shares and significant indirect holdings through trusts and a 401(k).
  • A large number of unvested Restricted Stock Units and unexercised Stock Options remain, aligning the director's future interests with the company's performance.

Negatives

  • A net disposition of 125,000 ordinary shares occurred through a combination of sales and shares withheld for taxes, reducing the director's direct beneficial ownership from the pre-transaction level.
  • While part of a planned monetization, the sale of shares by a director can sometimes be perceived as a signal of reduced confidence, though this is not explicitly stated in the filing.

Risks

  • Insider selling, even when pre-planned, can sometimes be misinterpreted by the market as a lack of confidence, potentially leading to negative sentiment or short-term share price volatility.
  • The value of remaining unvested equity awards is subject to future stock price fluctuations.

Future Outlook

The filing indicates future vesting events for various Restricted Stock Units, with payout dates ranging from March 8, 2024, to one year after March 7, 2025, for new grants. Several RSU awards have already vested but have deferred payout dates. Additionally, multiple tranches of stock options are outstanding with vesting schedules extending to March 8, 2022, and expiration dates up to March 8, 2031.

Industry Context

This Form 4 filing details an insider transaction, specifically a director's exercise of stock options and subsequent sale of shares. Such transactions are common for executives to monetize vested equity compensation and are typically pre-planned under Rule 10b5-1(c) to avoid accusations of trading on material non-public information. The filing does not provide information on broader industry trends or competitive landscape.

Comparison to Industry Standards

  • Not applicable for this filing, as it details individual insider transactions rather than company-wide financial or operational results.
  • The reported transactions, including the exercise of stock options and subsequent sale of shares, are common practices for executives to monetize vested equity awards, often executed under pre-arranged trading plans (Rule 10b5-1(c)).

Related Party Transactions

  • Indirect beneficial ownership of 71,029 ordinary shares through the 2010 Descendants Trust.
  • Indirect beneficial ownership of 20,517 ordinary shares through the 2012 Descendants Trust.
  • Indirect beneficial ownership of 2,268 ordinary shares in trust for children.

Stakeholder Impact

  • Shareholders: The transaction represents a director monetizing equity, which can be viewed as a realization of value from long-term incentives. The pre-planned nature (Rule 10b5-1(c)) mitigates concerns about opportunistic selling.
  • Employees: No direct impact on employees is indicated by this filing.

Next Steps

  • Future vesting and payout of various Restricted Stock Units on their respective scheduled dates.
  • Potential future exercise of remaining unexercised stock options prior to their expiration dates.

Key Dates

DateDescription
02/23/2016Grant date for a Restricted Stock Unit award.
02/28/2017Grant date for two Restricted Stock Unit awards.
02/28/2018Vesting start date for stock options and grant date for a Restricted Stock Unit award.
02/27/2019Vesting start date for stock options and grant date for a Restricted Stock Unit award.
03/20/2020Vesting start date for stock options and grant date for a Restricted Stock Unit award.
03/09/2021Vesting start date for stock options.
03/08/2022Vesting start date for stock options.
03/08/2024Vesting and payout date for certain Restricted Stock Units.
03/07/2025Grant date for a Restricted Stock Unit award.
08/07/2025Date of reported transactions, including option exercise and share dispositions.
08/08/2025Signature date of the Form 4 filing.
02/27/2028Expiration date for stock options granted February 27, 2019.
03/20/2029Expiration date for stock options granted March 20, 2020.
03/09/2030Expiration date for stock options granted March 9, 2021.
03/08/2031Expiration date for stock options granted March 8, 2022.

Recommendation

hold

While Director Stephen F. Angel sold a significant number of shares, this was entirely offset by the exercise of options, indicating a monetization event rather than a complete divestment. The director retains substantial direct and indirect holdings, including a large number of unexercised stock options and unvested restricted stock units, suggesting continued alignment with shareholder interests. The sale itself, while notable, does not fundamentally alter the company's operational outlook or financial health as presented in this filing, thus a 'hold' recommendation is appropriate.

Keywords

Linde PLC, LIN, Stephen F. Angel, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Share Sale, Director Transactions, Beneficial Ownership, Equity Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.